Neuropharmacology, the study of drugs that act on the nervous system, is a rapidly advancing field driven by the discovery of novel compounds with targeted mechanisms of action. YDL223C, also known as HBT1, stands out in this arena as a compound that effectively induces Brain-Derived Neurotrophic Factor (BDNF) and potentiates AMPA-R (alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors). This unique combination of properties makes it a compound of significant interest for a variety of neuropharmacological applications.
BDNF is a crucial neurotrophic factor that supports the health, growth, and survival of neurons. Its induction by YDL223C is key to its potential in neuroprotection and promoting neural plasticity. This means that YDL223C can help maintain existing neural pathways and potentially foster the development of new ones, which is vital for cognitive functions like learning and memory. For researchers looking to buy YDL223C, this mechanism offers a powerful avenue for study.
The potentiation of AMPA-R, another primary function of YDL223C, further enhances its utility in neuropharmacology. AMPA-R are ionotropic glutamate receptors that are critical for fast excitatory neurotransmission in the brain. By increasing the sensitivity or responsiveness of these receptors, YDL223C can amplify excitatory signaling, which is fundamental to synaptic strength and cognitive processes. This targeted action makes YDL223C a valuable API for developing treatments that modulate neural activity.
The applications for compounds like YDL223C are diverse, ranging from cognitive enhancement to the treatment of neurological disorders. Its role in improving memory, focus, and learning capacity is a primary focus for nootropic research. Simultaneously, its neuroprotective qualities and influence on neural health make it a candidate for investigating therapies for conditions such as Alzheimer's disease, depression, and anxiety disorders. The availability of YDL223C from suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is essential for advancing this research.
NINGBO INNO PHARMCHEM CO.,LTD. provides YDL223C to the scientific community, enabling researchers to explore its full potential in neuropharmacology. By offering this compound, NINGBO INNO PHARMCHEM CO.,LTD. supports the development of new treatments and cognitive enhancement strategies, contributing to the ongoing progress in understanding and improving brain function.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.